Quick Takeaways
- Enavate Sciences GP, LLC filed SCHEDULE 13D/A for Zenas BioPharma, Inc. Common Stock, par value $0.0001 per share (ZBIO).
- Disclosed ownership: 7.3%.
- Date of event: 09 Oct 2025.
Enavate Sciences GP, LLC - 09 Oct 2025 SCHEDULE 13D/A Report for Zenas BioPharma, Inc. Common Stock, par value $0.0001 per share (ZBIO)
- Filing Manager
- Enavate Sciences GP, LLC
- Reporting Manager
- Enavate Sciences GP, LLC
- Symbol
- ZBIO
- Shares outstanding
- 53,687,110 shares
- Disclosed Ownership
- 3,919,159 shares
- Ownership
- 7.3%
- Form type
- SCHEDULE 13D/A
- Filing time
- 14 Oct 2025, 17:29:58 UTC
- Date of event
- 09 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Enavate Sciences GP, LLC disclosed 7.3% ownership in Zenas BioPharma, Inc. Common Stock, par value $0.0001 per share (ZBIO) on 09 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Oct 2025, 17:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Enavate Sciences GP, LLC | 7.3% | 3,919,159 | 0 | 3,919,159 | /s/ James P. Boylan | By James P. Boylan, Manager | 0001953107 |
| Zebra Aggregator, LP | 7.3% | 3,919,159 | 0 | 3,919,159 | /s/ James P. Boylan | By: Enavate Sciences GP, LLC, its General Partner, By James P. Boylan, Manager | 0002037042 |